Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bone Loss|Breast Cancer
Interventions: DRUG: Zoledronic acid|DRUG: Letrozole
Sponsor: Novartis Pharmaceuticals